HIV-1 seroprevalence among women attending sexually transmitted disease clinics in California

M. J. Wilson, W. D. Marelich, G. F. Lemp, M. S. Ascher, P. Kerndt, Kenneth W Kizer

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

To evaluate the distribution of the human immunodeficiency virus type 1 (HIV-1) epidemic among California women, we analyzed HIV-1 seroprevalence and risk factors among women attending sexually transmitted disease (STD) clinics in 21 local health jurisdictions. Using standardized protocols developed by the Centers for Disease Control, we tested unlinked serum specimens from women attending participating STD clinics in 1989. We analyzed demographic characteristics, HIV risk exposure groups, and results of HIV-1 antibody testing on 17,210 specimens with an overall HIV-1 seroprevalence of 0.57%. Seroprevalence rates were highest for African-American women, women 25 to 29 years of age, injection drug users, and women attending STD clinics in San Francisco. After multiple logistic regression analysis, HIV-1 seropositivity remained highest for these four groups. The rate of HIV-1 infection among women attending STD clinics in California underscores the continued need to make HIV counseling and testing an integral component of routine services for women being evaluated for, or presenting with, sexually transmitted diseases.

Original languageEnglish (US)
Pages (from-to)40-43
Number of pages4
JournalWestern Journal of Medicine
Volume158
Issue number1
StatePublished - 1993

Fingerprint

Seroepidemiologic Studies
Sexually Transmitted Diseases
HIV-1
HIV
San Francisco
Virus Diseases
Centers for Disease Control and Prevention (U.S.)
Drug Users
African Americans
Counseling
Logistic Models
Regression Analysis
Demography
Injections
Antibodies
Health
Serum

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Wilson, M. J., Marelich, W. D., Lemp, G. F., Ascher, M. S., Kerndt, P., & Kizer, K. W. (1993). HIV-1 seroprevalence among women attending sexually transmitted disease clinics in California. Western Journal of Medicine, 158(1), 40-43.

HIV-1 seroprevalence among women attending sexually transmitted disease clinics in California. / Wilson, M. J.; Marelich, W. D.; Lemp, G. F.; Ascher, M. S.; Kerndt, P.; Kizer, Kenneth W.

In: Western Journal of Medicine, Vol. 158, No. 1, 1993, p. 40-43.

Research output: Contribution to journalArticle

Wilson, MJ, Marelich, WD, Lemp, GF, Ascher, MS, Kerndt, P & Kizer, KW 1993, 'HIV-1 seroprevalence among women attending sexually transmitted disease clinics in California', Western Journal of Medicine, vol. 158, no. 1, pp. 40-43.
Wilson, M. J. ; Marelich, W. D. ; Lemp, G. F. ; Ascher, M. S. ; Kerndt, P. ; Kizer, Kenneth W. / HIV-1 seroprevalence among women attending sexually transmitted disease clinics in California. In: Western Journal of Medicine. 1993 ; Vol. 158, No. 1. pp. 40-43.
@article{531fb1107a2e4b6ebbded470ddfc5f01,
title = "HIV-1 seroprevalence among women attending sexually transmitted disease clinics in California",
abstract = "To evaluate the distribution of the human immunodeficiency virus type 1 (HIV-1) epidemic among California women, we analyzed HIV-1 seroprevalence and risk factors among women attending sexually transmitted disease (STD) clinics in 21 local health jurisdictions. Using standardized protocols developed by the Centers for Disease Control, we tested unlinked serum specimens from women attending participating STD clinics in 1989. We analyzed demographic characteristics, HIV risk exposure groups, and results of HIV-1 antibody testing on 17,210 specimens with an overall HIV-1 seroprevalence of 0.57{\%}. Seroprevalence rates were highest for African-American women, women 25 to 29 years of age, injection drug users, and women attending STD clinics in San Francisco. After multiple logistic regression analysis, HIV-1 seropositivity remained highest for these four groups. The rate of HIV-1 infection among women attending STD clinics in California underscores the continued need to make HIV counseling and testing an integral component of routine services for women being evaluated for, or presenting with, sexually transmitted diseases.",
author = "Wilson, {M. J.} and Marelich, {W. D.} and Lemp, {G. F.} and Ascher, {M. S.} and P. Kerndt and Kizer, {Kenneth W}",
year = "1993",
language = "English (US)",
volume = "158",
pages = "40--43",
journal = "Western Journal of Medicine",
issn = "0093-0415",
publisher = "BMJ Publishing Group",
number = "1",

}

TY - JOUR

T1 - HIV-1 seroprevalence among women attending sexually transmitted disease clinics in California

AU - Wilson, M. J.

AU - Marelich, W. D.

AU - Lemp, G. F.

AU - Ascher, M. S.

AU - Kerndt, P.

AU - Kizer, Kenneth W

PY - 1993

Y1 - 1993

N2 - To evaluate the distribution of the human immunodeficiency virus type 1 (HIV-1) epidemic among California women, we analyzed HIV-1 seroprevalence and risk factors among women attending sexually transmitted disease (STD) clinics in 21 local health jurisdictions. Using standardized protocols developed by the Centers for Disease Control, we tested unlinked serum specimens from women attending participating STD clinics in 1989. We analyzed demographic characteristics, HIV risk exposure groups, and results of HIV-1 antibody testing on 17,210 specimens with an overall HIV-1 seroprevalence of 0.57%. Seroprevalence rates were highest for African-American women, women 25 to 29 years of age, injection drug users, and women attending STD clinics in San Francisco. After multiple logistic regression analysis, HIV-1 seropositivity remained highest for these four groups. The rate of HIV-1 infection among women attending STD clinics in California underscores the continued need to make HIV counseling and testing an integral component of routine services for women being evaluated for, or presenting with, sexually transmitted diseases.

AB - To evaluate the distribution of the human immunodeficiency virus type 1 (HIV-1) epidemic among California women, we analyzed HIV-1 seroprevalence and risk factors among women attending sexually transmitted disease (STD) clinics in 21 local health jurisdictions. Using standardized protocols developed by the Centers for Disease Control, we tested unlinked serum specimens from women attending participating STD clinics in 1989. We analyzed demographic characteristics, HIV risk exposure groups, and results of HIV-1 antibody testing on 17,210 specimens with an overall HIV-1 seroprevalence of 0.57%. Seroprevalence rates were highest for African-American women, women 25 to 29 years of age, injection drug users, and women attending STD clinics in San Francisco. After multiple logistic regression analysis, HIV-1 seropositivity remained highest for these four groups. The rate of HIV-1 infection among women attending STD clinics in California underscores the continued need to make HIV counseling and testing an integral component of routine services for women being evaluated for, or presenting with, sexually transmitted diseases.

UR - http://www.scopus.com/inward/record.url?scp=0027506853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027506853&partnerID=8YFLogxK

M3 - Article

VL - 158

SP - 40

EP - 43

JO - Western Journal of Medicine

JF - Western Journal of Medicine

SN - 0093-0415

IS - 1

ER -